Showing 8221-8230 of 18167 results for "".
- GLP-1 Receptor Agonists: A New Frontier in Managing Cancer Risk for Type 2 Diabeteshttps://reachmd.com/news/glp-1-receptor-agonists-a-new-frontier-in-managing-cancer-risk-for-type-2-diabetes/2471579/A recent study published in JAMA Network Open has revealed that patients with type 2 diabetes treated with GLP-1 receptor agonists may experience a significantly reduced risk of developing hematologic cancers compared to those on traditional therapies such as insulin and me
- ‘Sweat, Spike, Solve’: Research Suggests a New Strategy for People with Type 1 Diabetes to Lower Blood Sugar After Exercisehttps://reachmd.com/news/sweat-spike-solve-research-suggests-a-new-strategy-for-people-with-type-1-diabetes-to-lower-blood-sugar-after-exercise/2468400/Adults with Type 1 diabetes should perform aerobic cooldowns to manage high blood sugar after intense exercise where glucose levels might rise, according to current guidelines for managing the disease. However, this recommendation has never been empirica
- Tirzepatide for Type 2 Diabetes Associated with Lower Risks for Mortality, Adverse Heart, Kidney Eventshttps://reachmd.com/news/tirzepatide-for-type-2-diabetes-associated-with-lower-risks-for-mortality-adverse-heart-kidney-events/2467776/by Elana Gotkine For patients with type 2 diabetes, treatment with tirzepatide (a dual glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptor agonist) is associated with lower risks for all-cause mortality and adverse cardiovascular and kidney even
- Analysis Reveals the Global Burden of Type 1 Diabetes in Adults Aged 65 Years & Olderhttps://reachmd.com/news/analysis-reveals-the-global-burden-of-type-1-diabetes-in-adults-aged-65-years-older/2467078/The number of people aged 65 and older with type 1 diabetes increased from 1.3 million in 1990 to 3.7 million in 2019, while death rates fell 25% from 4.7 per 100,000 population in 1990 to 3.5 in 2019, finds an analysis of data from over 200 count
- Urolithin C alleviates Pancreatic β-Cell Dysfunction in Type 1 Diabetes by Activating Nrf2 Signalinghttps://reachmd.com/news/urolithin-c-alleviates-pancreatic-cell-dysfunction-in-type-1-diabetes-by-activating-nrf2-signaling/2457377/Type 1 diabetes (T1D) is an autoimmune disorder that destroys insulin-generating pancreatic β-cells. Preserving pancreatic β-cell function is important for treating T1D. Our study aims to explore the mechanism underlying urolithin C (UC)-mediated regulation of β-cell function.
- 13 New Biomarkers Could Help Better Predict Heart Disease Risk in People with Type 2 Diabeteshttps://reachmd.com/news/13-new-biomarkers-could-help-better-predict-heart-disease-risk-in-people-with-type-2-diabetes/2456995/An international academic consortium has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease risk in people with type 2 diabetes. The analysis, conducted by 23 experts from 11 countries, was led by The Johns Hopkins University in the United
- In Patients with NAFLD, Type 2 Diabetes Significantly Ups Risk for Hepatic Decompensation, Hepatocellular Carcinomahttps://reachmd.com/news/in-patients-with-nafld-type-2-diabetes-significantly-ups-risk-for-hepatic-decompensation-hepatocellular-carcinoma/2451795/In individuals with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D), the risk of hepatic decompensation and hepatocellular carcinoma (HCC) at 5 years was more than 3-fold greater than among those without T2D, according to new data from an int
- Exercise: A Vital Tool for Mitigating Diabetes Risk in Greenlandhttps://reachmd.com/news/exercise-a-vital-tool-for-mitigating-diabetes-risk-in-greenland/2470949/What's New New research identifies that exercise can improve insulin sensitivity in the muscles of Greenlandic Inuit individuals carrying a genetic variant that predisposes them to type 2 diabetes. Significance This discovery is significant because i
- Bariatric Surgery Outperforms GLP-1 Drugs in Slowing Kidney Disease Progression in Type 2 Diabeticshttps://reachmd.com/news/bariatric-surgery-outperforms-glp-1-drugs-in-slowing-kidney-disease-progression-in-type-2-diabetics/2468555/A recent study conducted by the Cleveland Clinic has revealed that bariatric surgery offers substantial kidney-protective benefits for patients with type 2 diabetes, obesity, and chronic kidney disease (CKD) compared to treatment with GLP-1 receptor agonist medications. Published in Annals of
- Study Finds Causal Links Between Type 1 Diabetes and Key Autoimmune Skin Diseaseshttps://reachmd.com/news/study-finds-causal-links-between-type-1-diabetes-and-key-autoimmune-skin-diseases/2467454/China: A recent study has unveiled significant associations between type 1 diabetes mellitus (T1DM) and various autoimmune skin diseases, employing Mendelian randomization (MR) to elucidate these links. This research, published in Heliyon Journal, highlights the potential for genet